Bharat Parenterals Ltd.

Financial

	Bharat Parenterals	Jagsonpal Pharma	Albert David
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	0.41 %	n/a	0.56 %
Financials
5 yr Average ROE	12.73 %	11.8 %	10.91 %
5yr average Equity Multiplier	1.76	1.31	1.72
5yr Average Asset Turnover Ratio	0.86	1.18	0.72
5yr Avg Net Profit Margin	8.73 %	7.67 %	9.03 %
Price to Book	5.06	4.79	1.97
P/E	68.76	39.96	10.03
5yr Avg Cash Conversion Cycle	122.06 Days	-6.79 Days	-57.55 Days
Inventory Days	46.56 Days	60.26 Days	47.31 Days
Days Receivable	179.99 Days	25.87 Days	28.0 Days
Days Payable	95.97 Days	67.96 Days	100.06 Days
5yr Average Interest Coverage Ratio	22.68	51.15	55.29
5yr Avg ROCE	16.02 %	15.71 %	14.73 %
5yr Avg Operating Profit Margin	15.57 %	11.17 %	15.62 %
5 yr average Debt to Equity	0.26	0.03	0.01
5yr CAGR Net Profit	-9.67 %	29.92 %	6.31 %
5yr Average Return on Assets	8.0 %	9.04 %	6.37 %
Shareholdings
Promoter Holding	73.27 %	68.09 %	62.13 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.15 %	-2.25 %	0.88 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Bharat Parenterals	Jagsonpal Pharma	Albert David
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0	Product Wise Break-Up Pharmaceutical 0 Others 100	Product Wise Break-Up Pharmaceutical 0 Others 100
Location Wise Break-Up	Location Wise Break-Up Rest of the World 62.53 India 37.47 Domestic 0	Location Wise Break-Up Rest of the World 0 India 97.66 India 0 Others 2.34	Location Wise Break-Up Rest of the World 4.59 Domestic 0 India 95.41